TrialPediatric dermatology2020

Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild-to-moderate atopic dermatitis.

Lawrence F Eichenfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.